A Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al. · Oncology · 2013 · 13.2K citations · Full text

Medicine, Cancer Biology, Oncology +17

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Soonmyung Paik, Steven Shak, Gong Tang et al. · New England Journal of Medicine · 2004 · 6.4K citations · Full text

Medicine, Oncology, Breast Oncology +12

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Soonmyung Paik, Gong Tang, Steven Shak et al. · Journal of Clinical Oncology · 2006 · 2.6K citations

Medicine, Cancer Biology, Oncology +17

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

Aleix Prat, Maggie C.U. Cheang, Miguel Martín et al. · Journal of Clinical Oncology · 2012 · 590 citations · Full text

Medicine, Cancer Biology, Oncology +17

TAILORx: Trial Assigning Individualized Options for Treatment (Rx)

Joseph A. Sparano · Clinical Breast Cancer · 2006 · 260 citations

Medicine, Pharmacotherapy, Clinical Decision Support +6